HK1075013A1 - Crystal modification of a cyclic depsipeptide having improved strength - Google Patents

Crystal modification of a cyclic depsipeptide having improved strength

Info

Publication number
HK1075013A1
HK1075013A1 HK05107422A HK05107422A HK1075013A1 HK 1075013 A1 HK1075013 A1 HK 1075013A1 HK 05107422 A HK05107422 A HK 05107422A HK 05107422 A HK05107422 A HK 05107422A HK 1075013 A1 HK1075013 A1 HK 1075013A1
Authority
HK
Hong Kong
Prior art keywords
cyclic depsipeptide
improved strength
crystal modification
depsipeptide
cyclic
Prior art date
Application number
HK05107422A
Other languages
English (en)
Inventor
Jochen Kalbe
Michael Traeubel
Achim Harder
Georg Von Samson-Himmelstjerna
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HK1075013A1 publication Critical patent/HK1075013A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK05107422A 2001-02-01 2005-08-24 Crystal modification of a cyclic depsipeptide having improved strength HK1075013A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
PCT/EP2002/000541 WO2002066048A1 (de) 2001-02-01 2002-01-21 Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit

Publications (1)

Publication Number Publication Date
HK1075013A1 true HK1075013A1 (en) 2005-12-02

Family

ID=7672376

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107422A HK1075013A1 (en) 2001-02-01 2005-08-24 Crystal modification of a cyclic depsipeptide having improved strength

Country Status (28)

Country Link
US (1) US20040115483A1 (pt)
EP (1) EP1357932B1 (pt)
JP (1) JP2004525111A (pt)
KR (2) KR20090041451A (pt)
CN (1) CN1278735C (pt)
AT (1) ATE284703T1 (pt)
AU (1) AU2002226415B2 (pt)
BR (1) BRPI0206841B8 (pt)
CA (1) CA2436832C (pt)
CR (1) CR7039A (pt)
CZ (1) CZ299564B6 (pt)
DE (2) DE10104362A1 (pt)
EE (1) EE05490B1 (pt)
ES (1) ES2233805T3 (pt)
HK (1) HK1075013A1 (pt)
HR (1) HRP20030635A2 (pt)
HU (1) HU229229B1 (pt)
IL (2) IL157026A0 (pt)
MX (1) MXPA03006866A (pt)
NO (1) NO331289B1 (pt)
NZ (1) NZ527230A (pt)
PL (1) PL213106B1 (pt)
PT (1) PT1357932E (pt)
RU (1) RU2300390C2 (pt)
SK (1) SK286280B6 (pt)
UA (1) UA74623C2 (pt)
WO (1) WO2002066048A1 (pt)
ZA (1) ZA200305864B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
WO1993019053A1 (fr) * 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Derive de depsipeptide, production et utilisation
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
EP0872481B1 (en) * 1995-06-30 2009-03-18 Astellas Pharma Inc. Depsipeptide derivative, process for production thereof, and novel intermediate therefor
IL123776A (en) * 1995-09-22 2002-09-12 Bayer Ag History of Cyclodepsipeptide 1022 PF
US6346603B1 (en) * 1997-11-10 2002-02-12 Fujisawa Pharmaceutical Co., Ltd. Crystal of depsipeptide derivative and process for producing the same
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Also Published As

Publication number Publication date
JP2004525111A (ja) 2004-08-19
CN1278735C (zh) 2006-10-11
NZ527230A (en) 2005-04-29
HRP20030635A2 (en) 2005-10-31
BRPI0206841B1 (pt) 2018-02-14
EE200300365A (et) 2003-10-15
US20040115483A1 (en) 2004-06-17
KR20030081378A (ko) 2003-10-17
DE50201777D1 (de) 2005-01-20
NO20033413D0 (no) 2003-07-30
NO20033413L (no) 2003-09-26
EP1357932B1 (de) 2004-12-15
CA2436832C (en) 2013-06-11
RU2003126589A (ru) 2005-02-27
BR0206841A (pt) 2004-02-25
DE10104362A1 (de) 2002-08-08
CZ20032063A3 (cs) 2003-11-12
PL213106B1 (pl) 2013-01-31
ES2233805T3 (es) 2005-06-16
CN1592631A (zh) 2005-03-09
SK9882003A3 (en) 2003-12-02
EP1357932A1 (de) 2003-11-05
CA2436832A1 (en) 2002-08-29
UA74623C2 (en) 2006-01-16
ATE284703T1 (de) 2005-01-15
AU2002226415B2 (en) 2007-03-22
BRPI0206841B8 (pt) 2021-05-25
ZA200305864B (en) 2004-08-27
WO2002066048A8 (de) 2003-11-20
RU2300390C2 (ru) 2007-06-10
HUP0302880A2 (hu) 2003-12-29
IL157026A (en) 2010-11-30
HU229229B1 (en) 2013-09-30
KR20090041451A (ko) 2009-04-28
CR7039A (es) 2004-06-08
WO2002066048A1 (de) 2002-08-29
MXPA03006866A (es) 2004-05-31
PT1357932E (pt) 2005-04-29
EE05490B1 (et) 2011-12-15
IL157026A0 (en) 2004-02-08
CZ299564B6 (cs) 2008-09-03
SK286280B6 (sk) 2008-06-06
PL362389A1 (en) 2004-11-02
HUP0302880A3 (en) 2005-05-30
NO331289B1 (no) 2011-11-21

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
HK1075013A1 (en) Crystal modification of a cyclic depsipeptide having improved strength
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200508214A (en) Novel compounds
TW200738658A (en) Novel compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
YU7804A (sh) Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
MY128924A (en) Novel compounds
RS99804A (en) Novel compounds and their use
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200740781A (en) Novel compounds
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03009602A (es) Analogos de nociceptina.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
MXPA02010952A (es) Composicion reductora para el tratamiento de las fibras queratinicas que comprende silicona aminada particular.
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
MXPA03005980A (es) Composiciones para administracion nasal de insulina.
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04005151A (es) Compuestos terapeuticos.
MXPA05003881A (es) Preparacion de compuestos triazospiro.

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220120